Loading provider…
Loading provider…
Surgery Physician in Houston, TX
NPI: 1265530992Primary Employer
Physicians Referral Service
mdanderson.org
HQ Phone
Get MD Abigail's Phone Numberphone_androidMobile
Get MD Abigail's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNC State Medical License
TX State Medical License
FL State Medical License
2021
GA State Medical License
2023 - 2027
TX State Medical License
2007 - 2027
AZ State Medical License
2023 - 2026
LA State Medical License
2023 - 2026
NC State Medical License
2000 - 2026
OK State Medical License
2020 - 2026
TN State Medical License
2023 - 2026
WA State Medical License
2023 - 2026
AL State Medical License
2023 - 2025
MS State Medical License
2023 - 2025

American Board of Surgery
Surgery
University of North Carolina School of Medicine
med.unc.edu
Medical School
Until 2000
University of North Carolina Hospitals
Residency • Surgery
2000 - 2005
Authors: Karen Hoffman, Thomas Buchholz, Isabelle Bedrosian, Tse-Kuan Yu, Jennifer Litton, Kelly Hunt, Funda Meric
Journal: Breast Cancer Res
Publication Date: 2012-05-23
ASO Visual Abstract: Residual Nodal Burden After Neoadjuvant Chemotherapy in cN1 Breast Cancer Patients with Positive Nodes on Targeted Axillary Dissection.
Authors: Susie Sun, Mediget Teshome, Kelly Hunt, Alexandra Moore, Benjamin Smith
Publication Date: 2024-08
Targeting and limiting surgery for patients with node-positive breast cancer.
Authors: Abigail Caudle, Henry Kuerer
Publication Date: 2015-04-14
Lead Sponsor: Endomagnetics Ltd.
Intervention / Treatment: DEVICE: Magseed Marker
Lead Sponsor: M.D. Anderson Cancer Center
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Localization, DEVICE: Medical Device, PROCEDURE: Axillary Lymph Node Dissection
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: fulvestrant, DRUG: anastrozole